| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
License revenue | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Operating expenses: | ||||||||||||
Research and development | ||||||||||||
33,419 | 30,163 | 27,787 | 25,356 | 21,257 | 20,346 | 13,825 | 18,268 | 17,419 | 17,066 | 0 | 0 | 0 |
General and administrative | ||||||||||||
17,527 | 17,640 | 17,091 | 15,095 | 12,156 | 8,739 | 4,926 | 4,994 | 5,111 | 5,181 | 0 | 0 | 0 |
Loss on transfer of nonfinancial assets | ||||||||||||
- | - | 0 | - | - | - | 0 | - | - | - | - | - | - |
Total operating expenses | ||||||||||||
54,846 | 51,703 | 48,882 | 40,451 | 33,413 | 29,085 | 18,751 | 23,262 | 22,530 | 22,247 | 0 | 0 | 0 |
Loss from operations | ||||||||||||
-51,846 | -51,703 | -48,882 | -40,451 | -33,413 | -29,085 | -18,751 | -23,262 | -22,530 | -22,247 | 0 | 0 | 0 |
Other expense: | ||||||||||||
Interest income | ||||||||||||
1,424 | 1,197 | 976 | 563 | 236 | 236 | 277 | 0 | 0 | - | 0 | - | - |
Grant and incentive income | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Interest expense | ||||||||||||
2,332 | 2,147 | 1,835 | 1,295 | 950 | 720 | -832 | -637 | -360 | 490 | 0 | 0 | 0 |
Change in fair value of preferred stock warrant liability | ||||||||||||
0 | 288 | 3,422 | 3,377 | 3,094 | 3,398 | 259 | 293 | 0 | - | 0 | 0 | - |
Change in fair value of derivative liability | ||||||||||||
0 | 183 | 505 | 500 | 659 | -89 | -1,267 | -1,262 | -1,421 | -94 | 0 | 0 | 0 |
Other income | ||||||||||||
558 | 517 | 201 | 0 | 0 | - | 0 | - | - | 0 | 0 | 0 | 0 |
Loss on extinguishment of debt | ||||||||||||
0 | - | 0 | - | 0 | - | 0 | - | - | - | - | 0 | - |
Total other expense, net | ||||||||||||
-1,078 | -1,104 | -4,370 | -3,689 | -3,378 | -4,200 | -2,556 | -1,043 | -1,446 | 253 | 0 | 0 | 0 |
Loss before provision for income taxes | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Provision for income taxes | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net loss | ||||||||||||
-53,072 | -52,807 | -53,252 | -44,140 | -36,791 | -33,285 | -21,307 | -24,305 | -23,976 | -21,994 | 0 | 0 | 0 |
Accruing dividends on Series A convertible preferred stock | ||||||||||||
0 | 592 | 1,348 | 2,104 | 2,852 | 3,000 | 0 | 0 | 0 | - | - | - | - |
Adjustment to accumulated deficit in connection with repurchase of Series Seed convertible preferred stock | ||||||||||||
- | - | 0 | - | - | - | 0 | 0 | - | - | - | - | - |
Accretion of redeemable convertible preferred stock to redemption value | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Net loss attributable to common stockholders | ||||||||||||
-53,072 | -53,399 | -54,600 | -46,244 | -39,665 | -36,307 | -26,537 | -28,795 | -27,709 | -24,994 | 0 | 0 | 0 |
Net loss per share attributable to common stock holders—basic and diluted (usd per share) | ||||||||||||
-0.56 | 4.28 | -1.22 | -1.02 | -6.67 | -26.23 | -20.39 | -14.83 | -17.70 | -10.36 | -22.60 | -11.13 | -10.49 |
Weighted average common shares outstanding—basic and diluted (in shares) | ||||||||||||
20,014 | 16,662 | 14,562 | 13,177 | 1,718 | 460 | 459 | 458 | 457 | 290 | 513 | 513 | 513 |
Net loss | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Currency translation adjustments | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Total comprehensive loss | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |